AEZS-108

zoptarelin doxorubicin · AEterna Zentaris

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AEZS-108, covering 2011-12-13 to 2018-03-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy [Phase 1, Phase 2]